Concentrations of Erlotinib in Tumor Tissue and Plasma in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Therapy - Lankheet, Nienke A.G.; Schaake, Eva E.; Burgers, Sjaak A.; van Pel, Renée; Beijnen, Jos H.; Huitema, Alwin D.R.; Klomp, Houke (Clinical lung cancer, 2015)
Keywords: Aged; Antineoplastic Agents - pharmacokinetics; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - pathology; Carcinoma, Non-Small-Cell Lung - surgery; Chromatography, High Pressure Liquid - methods; Erlotinib Hydrochloride - pharmacokinetics; Female; Hematology, Oncology and Palliative Medicine; Humans; Intratumoral drug concentration; Lung Neoplasms - drug therapy; Lung Neoplasms - pathology; Lung Neoplasms - surgery; Male; Middle Aged; Neoadjuvant Therapy; Neoadjuvant treatment; Pharmacokinetics; Pulmonary/Respiratory; Surgical resection; Tandem Mass Spectrometry; Time Factors; Tissue Distribution; Tyrosine kinase inhibitor; Surgical resection; Intratumoral drug concentration; Pharmacokinetics; Tyrosine kinase inhibitor; Neoadjuvant treatment